Refractory Urge Incontinence and Botox Injections.

Trial Profile

Refractory Urge Incontinence and Botox Injections.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 10 Jan 2011

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Overactive bladder; Urge incontinence
  • Focus Therapeutic Use
  • Acronyms RUBI
  • Most Recent Events

    • 10 Jan 2011 Status changed from completed to discontinued as reported by ClinicalTrials.gov. (NCT00373789)
    • 20 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Aug 2007 Interim results have been reported at the ICS 2007.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top